Searchable abstracts of presentations at key conferences in endocrinology

ea0050mc1.1 | Masterclass 1: Bone Masterclass | SFEBES2017

Osteoporosis management: the cutting edge

Abrahamsen Bo

We all encounter patients with osteoporosis in our daily practice - indeed the risk of osteoporotic fractures is increased in most endocrine disorders. The basic principles of diagnosing and treating osteoporosis and eliminating secondary causes remain simple and we should master them. However, providing truly excellent osteoporosis management is challenging and is much more than using the latest osteoporosis medication.There are challenges. Few clinicia...

ea0050mc1.1 | Masterclass 1: Bone Masterclass | SFEBES2017

Osteoporosis management: the cutting edge

Abrahamsen Bo

We all encounter patients with osteoporosis in our daily practice - indeed the risk of osteoporotic fractures is increased in most endocrine disorders. The basic principles of diagnosing and treating osteoporosis and eliminating secondary causes remain simple and we should master them. However, providing truly excellent osteoporosis management is challenging and is much more than using the latest osteoporosis medication.There are challenges. Few clinicia...

ea0028cmw2.3 | Controversies in aetiology and management of osteoporosis | SFEBES2012

Complications of antiresorptive agents

Abrahamsen Bo

Antiresorptive agents form an important part of the treatment strategy in almost every patient with osteoporosis. They are used both as the primary treatment option and as a means of maintaining gains in bone mass after bone anabolic therapy. Marketed drugs in this category comprise bisphosphonates, SERMs, calcitonin, and denosumab. By virtue of their effect on bone remodeling, potent antiresorptives have the potential to cause hypocalcaemia in susceptible patients (especially...

ea0063oc14.4 | Sex Hormones | ECE2019

Thyroid diseases in danish women with polycystic ovary syndrome

Glintborg Dorte , Hass Rubin Katrine , Nybo Mads , Abrahamsen Bo , Skovsager Andersen Marianne

Background: Polycystic ovary syndrome (PCOS) could be associated with increased risk of thyroid disorders. Possible associations between TSH and cardio-metabolic risk in PCOS are debated.Methods: National Register-based study on women with PCOS in Denmark. 18,476 women had a diagnosis of PCOS in the Danish National Patient Register. PCOS Odense University Hospital (OUH, N=1,146) was an embedded cohort including premenopausal women with PCOS and ...

ea0038oc2.5 | Translational pathophysiology and therapeutics | SFEBES2015

Age at first major osteoporotic fracture in Danes aged 50 and over: influence of diabetes on mean age at fracture and 1 year mortality

Abrahamsen Bo , Rosengren Bjorn , Prieto-Alhambra Daniel , Napoli Nicola , Cooper Cyrus

Diabetes mellitus (DM) is associated with an increased risk of fractures in excess of what would be expected from age and BMD. Further, DM is associated with increased risk of mortality in patients with hip fractures and possibly also other osteoporotic fractures.Study population and methods: Patients aged 50 or over who were treated for fractures of the hip, forearm, humerus and spine over 6 years (2004–2009, n=146 256) not coded as road t...

ea0056gp127 | Female Reproduction | ECE2018

Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome

Glintborg Dorte , Rubin Katrine Hass , Nybo Mads , Abrahamsen Bo , Andersen Marianne Skovsager

Background: Polycystic ovary syndrome (PCOS) is associated with obesity and low grade inflammation, factors linked to cardiovascular disease (CVD).Methods: National Register-based study including women with PCOS and no previous diagnosis of CVD or hypertension. PCOS OUH (n=1165) included premenopausal women with PCOS and clinical and biochemical examination. PCOS Denmark (n=18 112) included women with PCOS in the Danish National Patient...

ea0094ec1.3 | Clinical Endocrinology Trust Best Abstract Clinical | SFEBES2023

Biological heterogeneity in skeletal susceptibility to glucocorticoid induced bone loss: Short- and long-term BMD trajectories during unopposed GC treatment in adults

Bakke Hansen Benjamin , Rubin Katrine , Hermann Pernille , Frost Munk Nielsen Morten , Abrahamsen Bo

Objective: Describe short- and long-term changes in BMD in adults exposed to varying intensities of systemic glucocorticoid (GC) treatment.MethodsSetting: Danish Public Health Service Hospital, catchment area 500,000 individuals.Data: BMD data from 2006-2021 and data on filled prescriptions.Analysis: All adult patients with at least two DXA e...